Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy: An in vivo PET study

Circulation

Volumn 96, Issue 10, 1997, Pages 3416-3422

  Le Guludec, Dominique ^a   Cohen Solal, Alain ^b   Delforge, Jacques ^c   Delahaye, Nicolas ^a   Syrota, André ^c   Merlet, Pascal ^c  

^a BICHAT HOSPITAL   (France)

^b BEAUJON HOSPITAL   (France)

^c DIF   (France)

Author keywords

Heart failure; Nervous system, autonomic; Receptors

Indexed keywords

ADENYLATE CYCLASE; CARBON 11; GUANINE NUCLEOTIDE BINDING PROTEIN; HEART ENZYME; HEART RECEPTOR; MUSCARINIC RECEPTOR; QUINUCLIDINYL BENZILATE;

ADULT; AGED; ARTICLE; BETA ADRENERGIC STIMULATION; BLOOD VESSEL TONE; CHOLINERGIC STIMULATION; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION;

EID: 0030785471     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.10.3416     Document Type: Article

References (55)

1. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
2. Denniss AR, Marsh JD, Quigg RJ, Gordon JB, Colucci WS. β-Adrenergic receptor number and adenylate cyclase function in denervated, transplanted and cardiomyopathic human hearts. Circulation. 1989;79:1028-1034.
3. Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, Feldman AM. β-Adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation. 1990;82:(suppl I);I-12-I-25.
4. Schmitz W, Boknik P, Linck B, Muller FU. Adrenergic and muscarinic receptor regulation and therapeutic implications in heart failure. Mol Cell Biochem. 1996;157:251-258.
5. De Ferrari GM, Salvati P, Grossoni M, Ukmar G, Vaga L, Patrono C, Schwartz PJ. Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. J Am Coll Cardiol. 1993;21:283-290.
6. Hermosillo AG, Dorado M, Casanova MJ, Ponce de Leon S, Cossio J, Kersenovich S, Colin L, Iturralde P. Influence of infarct-related artery patency on the indexes of parasympathetic activity and prevalence of late potentials in survivors of acute myocardial infarction. J Am Coll Cardiol. 1993;22:695-706.
7. Pedretti RF, Colombo E, Braga SS, Ballardini L, Caru B. Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction. J Am Coll Cardiol. 1995;25:915-921.
8. Binder T, Frey B, Porenta G, Heinz G, Wutte M, Kreiner G, Gossinger H, Schmidinger H, Pacher R, Weber H. Prognostic value of heart rate variability in patients awaiting cardiac transplantation. PACE. 1992;15:2215-2220.
9. Casolo G, Balli E, Taddei T, Amuhasi J, Gori C. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol. 1989;64:1162-1167.
10. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med. 1971;285:877-883.
11. Saul PJ, Arai Y, Berger RD, Lilly LS, Colucci WS, Cohen RJ. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Circulation. 1988;61: 1292-1299.
12. Binkley PF, Nunziata E, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol. 1991;18:464-472.
13. Nolan J, Flapan AD, Capwewell S, Mac Donald TM, Neilson JMM, Ewing DJ. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Br Heart J. 1992;67:482-485.
14. Eaton GM, Cody RJ, Nunziata E, Binkley PF. Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced canine model of congestive heart failure. Circulation. 1995;92:555-561.
15. Zuanetti G, Ferrari GM, Priori SG, Schwartz PJ. Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res. 1987;61:429-435.
16. Tuininga YS, Van Veldhuisen DJ, Brouwer J, Haaksma J, Crijus HJGM, Man in't Veld AJ, Lie KI. Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. Br Heart J. 1994;72:509-513.
17. La Rovere MT, Mottana A, Pantaleo P, Cobelli F, Tavazzi L. Scopolamine improves autonomic balance in advanced congestive heart failure. Circulation. 1994;90:838-843.
18. Casadei B, Conway J, Sleight P. Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure. Heart. 1996;75: 274-280.
19. Venkatesh G, Fallen EL, Kamath MV, Connolly S, Yusuf S. Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with congestive heart failure. Heart. 1996;76:137-143.
20. Henning RJ, Khalil IR, Levy MN. Vagal stimulation attenuates sympathetic enhancement of left ventricular function. Am J Physiol. 1990;258:H1470-H1475.
21. Landzberg JS, Parker JD, Gautheir DF, Colucci WS. Effects of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility. Circulation. 1994;89: 164-168.
22. Parker JD, Colucci WS, Landzberg JS, Schofield AM. Effects of myocardial muscarinic stimulation on dobutamine stimulated inotrope responses in the normal and failing human left ventricle. J Am Coll Cardiol. 1994(special issue);(suppl A):454A.
23. Vatner DE, Lee DL, Schwarz KR, Longabauch JP, Fujii AM, Vatner SF, Homey CJ. Impaired cardiac muscarinic receptor function in dogs with heart failure. J Clin Invest. 1988;81:1836-1842.
24. iα in human hearts with dilated but not ischemic cardiomyopathy. Circulation. 1990;82:1249-1265.
25. Habecker BA, Tietje KM, Vankoppen CJ, Creason SA, Goldman PS, Migeon JC, Parenteau LA, Nathanson NM. Regulation of expression and function of muscarinic receptors. Life Sci. 1993;52: 429-432.
26. Balligand JL, Kelly RA, Marsdern PA, Smith WS, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
27. 1 during pacing-induced heart failure. Circulation. 1996;94: 102-107.
28. Delforge J, Janier M, Syrota A, Crouzel C, Vallois JM, Cayla J, Lancon JP, Mazoyer B. Noninvasive quantification of muscarinic receptors in vivo with positron emission tomography in the dog heart. Circulation. 1990;82:1494-1504.
29. Delforge J, Le Guludec D, Syrota A, Bendriem B, Crouzel C, Slama M, Merlet P. In vivo quantification of myocardial muscarinic receptors in human with PET. J Nucl Med. 1993;34:981-991.
30. Le Guludec D, Delforge J, Syrota A, Desruennes M, Valette H, Gandjbakhch I, Merlet P. In vivo quantification of myocardial muscarinic receptors in heart transplant patients. Circulation. 1994; 90:172-178.
31. Trebossen R, Mazoyer B. Count rate performances of TTV03: the CEA-LETI time-of-flight positron emission tomograph. IEEE Trans Med Imaging. 1991;10:261-266.
32. Brown MJ, Jenner DA. Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision sensitivity and plasma sample capacity. Clin Sci. 1981;61:591-598.
33. Wharton J, Polak J, Gordon L, Banner N, Sprinall D, Rose M, Khagani A, Wallwork J, Yacoub M: Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res. 1990;66:900-912.
34. Degrado TR, Mulholland KG, Wieland DM, Schwaiger M. Evaluation of F-18 fluoroethoxybenzovesamicol as a new PET tracer of cholinergic neurons of the heart. Nucl Med Biol. 1994;21:189-195.
35. Valette H, Syrota A, Fuseau C. Down-regulation of cardiac muscarinic receptors induced by diisopropylfluorophosphate: comparison of in vivo and in vitro measurements. J Nucl Med. 1997;38:1630-1633.
36. Hollenberg M, Carriere S, Barger AC. Biphasic effect of acetylcholine on ventricular myocardium. Circ Res. 1965;16:527-536.
37. Xenopulos NP, Applegate RJ. The effect of vagal stimulation on left ventricular systolic and diastolic performance. Am J Physiol. 1994;266:H2167-H2173.
38. Stratton JR, Pfeifer MA, Halter JB. The hemodynamic effects of sympathetic stimulation combined with parasympathetic blockade in man. Circulation. 1987;75:922-929.
39. Hare JM, Keaney JF, Balligand JL, Loscalzo J, Smith TW, Colucci WS. Role of nitric oxide in parasympathetic modulation of β-adrenergic myocardial contractility in normal dogs. J Clin Invest. 1995;95:360-366.
40. Koglin J, Böhm M, von Scheidt W, Stäblein A, Erdmann E. Antiadrenergic effect of carbachol but not of adenosine on contractility in the intact human ventricle in vivo. J Am Coll Cardiol. 1994;23:678-683.
41. Bartel S, Karczewski P, Krause EG. Protein phosphorylation and cardiac function: cholinergic-adrenergic interaction. Cardiovasc Res. 1993;27:1948-1953.
42. Feldman AM. Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. Circulation. 1993;87(suppl IV):IV-27-IV-34.
43. Karczewski P, Bartel S, Krause EG. Protein phosphorylation and cardiac function: cholinergic-adrenergic interaction. Cardiovasc Res. 1993;27:1948-1953.
44. i-α in failing human heart with dilated cardiomyopathy. Cardiovasc Res. 1992;26:950-955.
45. Ohkuma S, Kishi M, Ma FH, Kuriyama K. Alterations in receptor-coupled second messenger systems at upregulated muscarinic receptors: analysis using primary cultured neurons. Eur J Pharmacol. 1990;189:277-285.
46. 2 receptors in transfected fibroblast B82 cells. Eur J Pharmacol. 1994;268:381-391.
47. 2-muscarinic receptors increase in the canine pacing-overdrive model of heart failure. Can J Cardiol. 1996;12:71-76.
48. i protein mediated muscarinic receptor adenylyl cyclase in chronic ischaemic heart failure in the rat. Cardiovasc Res. 1993;27:2065-2070.
49. Schmidt U, Schwinger RHG, Bohm M. Interaction of halothane with inhibitory G-proteins in the human myocardium. Anesthesiology. 1995;82:353-360.
50. Galper JB, Dziekan LC, O'Hara DS, Smith TW. The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. J Biol Chem. 1986;257:10344-10356.
51. Böhm M, Ungere M, Erdmann E. Adenosine receptors in the human heart: pharmacological characterization in nondisease and cardiomyopathic tissue. Drug Development Res. 1993;28:268-276.
52. 2 receptors of the adenylyl cyclase system. J Mol Cell Cardiol. 1992;24: 535-548.
53. Krum H, Bigger TJ, Goldsmith RL, Packer M. Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol. 1995;25:289-294.
54. Osterziel KJ, Hanlein D, Dietz R. Interactions between the reninangiotensin system and the parasympathetic nervous system in heart failure. J Cardiovasc Pharmacol. 1994;24(suppl 2):S70-S74.
55. Townend JN, Littler WA. Cardiac vagal activity: a target for intervention in heart disease. Lancet. 1995;345:937-938.